Jiajia Li

Title: Jiajia Li: Innovator in Recombinant Collagen Technology

Introduction

Jiajia Li is a prominent inventor based in Changzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant collagen. With a total of 2 patents to his name, his work is paving the way for advancements in medical technology.

Latest Patents

Jiajia Li's latest patents include innovative methods for producing recombinant collagen. One of his notable inventions is a recombinant collagen and preparation method that focuses on a full-length collagen α1 chain produced through recombinant expression. This invention aims to eliminate the main degradation product during the recombinant expression process, thereby improving the yield of the target product. Another significant patent is for recombinant human type XVII collagen, which can be efficiently expressed in eukaryotic host cells. This collagen consists of a specific amino acid sequence and has potential applications in various medical fields.

Career Highlights

Jiajia Li is currently associated with Jiangsu Trautec Medical Technology Co., Ltd., where he continues to innovate in the field of medical technology. His work is characterized by a strong focus on enhancing the efficiency and effectiveness of collagen production, which is crucial for various therapeutic applications.

Collaborations

Throughout his career, Jiajia Li has collaborated with notable colleagues, including Liping Wang and Song Qian. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jiajia Li's contributions to recombinant collagen technology are noteworthy and have the potential to impact the medical field significantly. His innovative patents reflect a commitment to advancing biotechnology and improving therapeutic options.